Valuation : PolyNovo Limited

Market Cap 712M 513M 441M 415M 379M 710M 48.43B 4.91B 1.9B 24.85B 1.93B 1.88B 80.04B P/E 2027 *
73.1x
P/E 2028 * 35x
Enterprise Value 671M 484M 416M 392M 358M 669M 45.69B 4.63B 1.8B 23.44B 1.82B 1.78B 75.51B EV / Sales 2027 *
4.15x
EV / Sales 2028 * 3.53x
Free-Float
88.97%
Yield 2027 *
-
Yield 2028 * -
1 day+0.97%
1 week+3.48%
Current month+3.48%
1 month+18.86%
6 months+18.86%
Current year-15.45%
1 week 0.98
Extreme 0.975
1.07
1 month 0.88
Extreme 0.88
1.17
Current year 0.81
Extreme 0.81
1.3
1 year 0.81
Extreme 0.81
1.66
3 years 0.81
Extreme 0.81
2.78
5 years 0.81
Extreme 0.81
2.78
10 years 0.17
Extreme 0.17
4.08
Manager TitleAgeSince
Chief Executive Officer - 01/12/2025
Director of Finance/CFO - 12/12/2018
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Chairman - 27/10/2025
Director/Board Member 65 28/10/2019
Director/Board Member - 13/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
3/16/26 A Buy

Director

151,000 0.0219%
2/27/26 A Buy

Director

100,000 0.0145%
2/27/26 A Buy

Chairman

30,000 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%+3.48%-29.25%-20.00% 513M
-0.42%-3.68%-18.51%+6.67% 187B
+1.15%+3.22%+1.37%+16.68% 120B
-1.86%+2.77%+13.15%+89.47% 63.15B
+0.02%-1.85%+16.33%+49.92% 51.75B
-1.54%-2.52%-3.98%-30.72% 50.32B
-2.02%-3.22%+9.18%-17.76% 33.17B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+35.59%-16.03% 23.93B
-2.41%-5.66%-10.69%+8.23% 22.99B
Average -0.69%-0.52%+1.47%+9.61% 58.58B
Weighted average by Cap. -0.47%-0.64%-1.69%+16.53%

Financials

2027 *2028 *
Net sales 162M 117M 100M 94.41M 86.24M 161M 11.01B 1.12B 433M 5.65B 438M 428M 18.2B 186M 134M 115M 108M 98.94M 185M 12.63B 1.28B 497M 6.48B 502M 491M 20.88B
Net income 9.77M 7.04M 6.06M 5.7M 5.21M 9.75M 665M 67.4M 26.15M 341M 26.45M 25.88M 1.1B 20.34M 14.66M 12.61M 11.87M 10.84M 20.28M 1.38B 140M 54.42M 710M 55.05M 53.85M 2.29B
Net Debt -40.27M -29.03M -24.98M -23.5M -21.47M -40.16M -2.74B -278M -108M -1.41B -109M -107M -4.53B -57.04M -41.12M -35.38M -33.29M -30.41M -56.88M -3.88B -393M -153M -1.99B -154M -151M -6.42B
Logo PolyNovo Limited
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.
Employees
301
Date Price Change Volume
07/09/26 A$1.040 +0.97% 3,344,262
04/09/26 A$1.030 +0.98% 1,206,616
03/09/26 A$1.020 +2.00% 1,643,444
02/09/26 A$1.000 -0.50% 1,538,028
01/09/26 A$1.005 0.00% 1,182,114
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1.030AUD
Average target price
1.247AUD
Spread / Average Target
+21.10%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!